The correlation between the increase rate of serum creatininelevels and long-term adverse clinical outcomes in patientswith non st-segment elevation myocardial infarction
We classified the patients into 3 groups according to theincrease rates in SCrea values; first group(∆SCrea
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Aim: We purposed to evaluate the correlation between the rate of increase in SCrea levels and major adverse cardiac andcerebrovascular events(MACCE) in non ST-segment elevation myocardial infarction(NSTEMI) patients who was made coronaryangiography(CAG) in this study.
📊
Key Findings & Data:According to studies on especially stable coronary artery disease (SCAD); contrast-induced acutekidney injury CI-AKI) is described as an rising in serum creatinine (SCrea) levels more than 0.5 mg / dl or more than 25% within 48-72hours after the contrast agent implementation.
💡
Conclusion & Impact:We classified the patients into 3 groups according to theincrease rates in SCrea values; first group(∆SCrea
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Aim: We purposed to evaluate the correlation between the rate of increase in SCrea levels and major adverse cardiac andcerebrovascular events(MACCE) in non ST-segment elevation myocardial infarction(NSTEMI) patients who was made coronaryangiography(CAG) in this study. According to studies on especially stable coronary artery disease (SCAD); contrast-induced acutekidney injury CI-AKI) is described as an rising in serum creatinine (SCrea) levels more than 0.5 mg / dl or more than 25% within 48-72hours after the contrast agent implementation. However, data on the increase rates of SCrea levels in patients with acute coronarysyndrome (ACS) are insufficient.. Materials and Methods: 884 NSTEMI patients were admitted to our study. We classified the patients into 3 groups according to theincrease rates in SCrea values; first group(∆SCrea
🔖
Cite This Article
Arslan, Ş. (2022). The correlation between the increase rate of serum creatininelevels and long-term adverse clinical outcomes in patientswith non st-segment elevation myocardial infarction. Annals of Medical Research, Cilt: 28 - Sayı: 3, 520–526. https://ajindex.com/articles/445928
Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393-9
McCullough PA, Adam A, Becker CR, et al. CIN Consensus Working Panel. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 200618;98:5-13
Kidney Disease: Improving Global Outcomes (KDIGO) AKI Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Inter Suppl 2012;2:1–138
Morcos SK. Contrast medium-induced nephrotoxicity. In: Dawson P, Cosgrove DO, Grainger RG, editors. Textbook of Contrast Media. Oxford, England: Isis Medical Media Ltd 1999:135-48
Nikolsky E, Aymong ED, Dangas G, et al. Radio contrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function. Rev Cardiovasc Med 2003;4(suppl 1):7-14
Harjai KJ, Raizada A, Shenoy C, et al. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol 2008;101:812-9
Leoncini M, Toso A, Maioli A, et al. Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and anti- platelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study. Am Heart J 2014;168:792–7
Ruparelia N, Digby JE, Jefferson A, et al. Myocardial infarction causes inflammation and leukocyte recruitment at remote sites in the myocardium and in the renal glomerulus. Inflamm Res 2013;62:515–25
Narula A, Mehran R, Weisz G, et al. Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONSAMI substudy. Eur Heart J 2014;35:1533-40
Uzunhasan I, Yildiz A, Arslan S, et al. ContrastInduced Acute Kidney Injury Is Associated With LongTerm Adverse Events in Patients With Acute Coronary syndrome. Angiology 2017;68:621-6
Abaci O, Arat Ozkan A, Kocas C, et al. Impact of Rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography. Am J Cardiol 2015;115:867-71
Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120:c179-84
Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network. Acute Kidney Injury N